Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Xap Therapeutics logo — Nature gave us the parts. We provide the blueprints.

Xap Therapeutics

Nature gave us the parts. We provide the blueprints.

Founded 2017 United Kingdom Cambridge, United Kingdom 34 employees Series Unknown Biotechnology, Health Care

General Information

Company Name Xap Therapeutics
Founded Year 2017
Location United Kingdom Cambridge, United Kingdom +1
Employees 34
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Xap Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Xap Therapeutics

Xap Therapeutics (formerly known as Rockend Ltd.) is a biotechnology company based in Cambridge, UK, established in 2017. The company has garnered significant attention from well-known US/UK blue-chip VCs, with the latest Venture Round investment led by Amplitude Ventures in January 2020. Xap Therapeutics stands out with its innovative approach to synthetic biology and cell therapeutics, employing CRISPR technology to engineer induced pluripotent stem cells (iPSCs) as the foundation for a universal cell platform. This platform aims to create a "chassis" cell that can be further functionalized into cell therapies, capable of processing external cues and releasing various types of cargos upon activation. The company's vision is to develop novel cell therapies with mechanisms of action beyond current approaches, offering a significant leap in the treatment of serious diseases such as autoimmunity and cancer. Xap Therapeutics is rapidly expanding its team, welcoming individuals from industry and academia to contribute to the development of the synthetic cell therapy platform and future clinical products. The company offers a dynamic and innovative working environment, positioning itself as an enticing career opportunity for talented individuals in the field of biotechnology and healthcare.

Taxonomy: synthetic biology, cell therapeutics, CRISPR technology, iPSCs, cell engineering, universal cell platform, cell therapies, genetic engineering, novel cell therapies, autoimmunity, cancer treatment, R&D, team building, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jan 2020

Xap Therapeutics Alternatives & Competitors

Xap Therapeutics vs
Fate Therapeutics Inc.
Fate Therapeutics Inc. United States

Transforming the lives of patients with autoimmune diseases and cancer.

Unknown
227 employees
Biotechnology, Health Care
Compare Xap Therapeutics vs Fate Therapeutics Inc.
Xap Therapeutics vs
bit.bio
bit.bio United Kingdom

The Cell Coding Company

Series C
164 employees
Biotechnology, Health Care
Compare Xap Therapeutics vs bit.bio
Xap Therapeutics vs
Garuda Therapeutics
Garuda Therapeutics United States

Creating off-the-shelf, long-term durable blood stem cell therapies

Series B
9 employees
Biotechnology, Health Care
Compare Xap Therapeutics vs Garuda Therapeutics

FAQ About Xap Therapeutics

Nature gave us the parts. We provide the blueprints.
Xap Therapeutics was founded in 2017.
Xap Therapeutics is headquartered in Cambridge, United Kingdom.
Xap Therapeutics operates in the following industries: Biotechnology, Health Care.
Xap Therapeutics has approximately 34 employees.
Xap Therapeutics has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to Xap Therapeutics include Fate Therapeutics Inc., bit.bio, Garuda Therapeutics, Engimmune Therapeutics, TScan Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Xap Therapeutics and Fate Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Xap Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy